Modern biological research frequently generates high-dimensional datasets where the number of measured variables—such as metabolites, lipids, or transcripts—far exceeds the number of samples. In studies ranging from the freezing resistance of tea plants Hui Wu et al. to the metabolic signatures of Parkinson’s disease Gaia Meoni et al., the challenge is to distill these thousands of data points into a clear "fingerprint" that distinguishes one biological state from another.
To achieve this, researchers rely on a hierarchy of multivariate statistical methods that reduce dimensionality while preserving the most meaningful biological signals.
Unsupervised Exploration via Principal Component Analysis
The first step in analyzing complex omics data is typically Principal Component Analysis (PCA). PCA is an "unsupervised" method, meaning it processes the data without knowing which samples belong to which group (e.g., healthy vs. diseased).
As noted by Lei Gao et al., PCA provides an essential overview of the dataset, allowing researchers to visualize sample similarities and identify outliers. By mathematically rotating the data to find the directions (principal components) of greatest variance, PCA collapses hundreds of metabolites into a two- or three-dimensional plot. If the experimental groups naturally cluster apart in this plot, it suggests that the biological differences are the dominant source of variation in the data.
Supervised Discrimination with PLS-DA
When biological differences are subtle or masked by noise, researchers turn to "supervised" methods like Partial Least Squares-Discriminant Analysis (PLS-DA). Unlike PCA, PLS-DA is informed by sample labels. It specifically seeks out the variation that correlates with the class of interest, such as distinguishing between different varieties of medicinal herbs Jinmei Ou et al. or identifying the effects of plant growth regulators Yue Ren.
By modeling the relationship between the predictor variables (metabolites) and a categorical response (the group label), PLS-DA can construct predictive models. For instance, Jun Yu utilized PLS-DA to identify specific microbial signatures that could discriminate between different clinical states of liver disease.
Isolating the Signal with OPLS-DA
The most refined tool in this pipeline is Orthogonal Partial Least Squares-Discriminant Analysis (OPLS-DA). While standard PLS-DA captures all variation related to the groups, OPLS-DA goes a step further by separating the variation into two parts: "predictive" variation (related to the group) and "orthogonal" variation (unrelated noise).
This separation is crucial for interpretability. As Yan Yang et al. explain, OPLS-DA filters out structured noise that is uncorrelated to the response variable, enhancing the visibility of the metabolites that truly drive the differences between groups. This method has been used to pinpoint metabolic shifts in the gut-brain axis of children with ADHD Dingding Han et al. and to identify the biological "memory" of famine exposure in diabetic adults Heng Wan.
From Patterns to Biomarkers
The ultimate goal of these multivariate models is often biomarker discovery. Researchers identify the most influential variables using the Variable Importance in Projection (VIP) score. A high VIP score indicates that a specific metabolite contributes significantly to the separation between groups in the OPLS-DA model.
For example, Xiaogang Li et al. used VIP scores to identify specific triacylglycerols as potential biomarkers for hip dysplasia, while Yue Zhang et al. used them to authenticate closely related ginger species. By combining these scores with univariate statistics like p-values, researchers can move from a broad "fingerprint" to a specific set of molecules that define a biological condition.